# Local Paclitaxel Delivery for SFA Disease

> **NCT00821028** · NA · COMPLETED · sponsor: **University of Oklahoma** · enrollment: 27 (actual)

## Conditions studied

- Atherosclerosis
- Angioplasty
- Peripheral Arterial Disease

## Interventions

- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT00821028
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2011-12
- **Final completion:** 2012-04
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2026-04-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00821028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00821028, "Local Paclitaxel Delivery for SFA Disease". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00821028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*